benzoylarginine nitroanilide and Alveolar Bone Atrophy

benzoylarginine nitroanilide has been researched along with Alveolar Bone Atrophy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balejo, RD; Cortelli, JR; Cortelli, SC; Holzhausen, M; Lara, GM; Saad, WA	1

Other Studies

1 other study(ies) available for benzoylarginine nitroanilide and Alveolar Bone Atrophy

Article	Year
Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats. Clinical oral investigations, 2011, Volume: 15, Issue:6 Topics: Alveolar Bone Loss; Animals; Benzamidines; Benzoylarginine Nitroanilide; Cell Movement; Chromogenic Compounds; Gingiva; Gingivitis; Granulocytes; Guanidines; Male; Mandibular Diseases; Molar; Peptide Hydrolases; Periodontitis; Peroxidase; Random Allocation; Rats; Rats, Wistar; Receptor, PAR-2; Time Factors; Trypsin Inhibitors; Tryptases	2011

Article

Year

Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.

Clinical oral investigations, 2011, Volume: 15, Issue:6

Topics: Alveolar Bone Loss; Animals; Benzamidines; Benzoylarginine Nitroanilide; Cell Movement; Chromogenic Compounds; Gingiva; Gingivitis; Granulocytes; Guanidines; Male; Mandibular Diseases; Molar; Peptide Hydrolases; Periodontitis; Peroxidase; Random Allocation; Rats; Rats, Wistar; Receptor, PAR-2; Time Factors; Trypsin Inhibitors; Tryptases

2011